Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Brightling

Showing results (51-60 of 295) with videos related to

Pageof 30
Sort By:
The New England Journal of Medicine|October 27, 2021
Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled TrialChristopher E Brightling, Parameswaran Nair, David J Cousins, et al.
Chest|January 24, 2006
An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelinesMelvin R Pratter, Christopher E Brightling, Louis Philippe Boulet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 13, 2012
Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthmaRachel L Clifford, Alison E John, Christopher E Brightling, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 18, 2014
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trialRoshan Siva, Mona Bafadhel, William Monteiro, et al.
The Lancet. Respiratory Medicine|October 20, 2023
Long COVID research: an update from the PHOSP-COVID Scientific SummitChristopher E Brightling, Rachael A Evans, Amisha Singapuri, et al.
Peptides|November 6, 2012
The effects of nociceptin peptide (N/OFQ)-receptor (NOP) system activation in the airwaysShailendra R Singh, Nikol Sullo, Bruno D'Agostino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoterAlison E John, Yong M Zhu, Christopher E Brightling, et al.
Chest|April 12, 2002
A comparison of the validity of different diagnostic tests in adults with asthmaCameron J Hunter, Christopher E Brightling, Gerrit Woltmann, et al.
American Journal of Respiratory Cell and Molecular Biology|December 10, 2014
Cigarette Smoke and the Induction of Urokinase Plasminogen Activator Receptor In Vivo: Selective Contribution of Isoforms to Bronchial Epithelial PhenotypeMichael A Portelli, Ceri E Stewart, Ian P Hall, et al.
Journal of Leukocyte Biology|January 28, 2005
Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migrationChristopher E Brightling, Davinder Kaur, Patrick Berger, et al.
Pageof 30

Showing results (51-60 of 295) with videos related to

Sort By:
Pageof 30
The New England Journal of Medicine|October 27, 2021
Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled TrialChristopher E Brightling, Parameswaran Nair, David J Cousins, et al.
Chest|January 24, 2006
An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelinesMelvin R Pratter, Christopher E Brightling, Louis Philippe Boulet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 13, 2012
Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthmaRachel L Clifford, Alison E John, Christopher E Brightling, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 18, 2014
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trialRoshan Siva, Mona Bafadhel, William Monteiro, et al.
The Lancet. Respiratory Medicine|October 20, 2023
Long COVID research: an update from the PHOSP-COVID Scientific SummitChristopher E Brightling, Rachael A Evans, Amisha Singapuri, et al.
Peptides|November 6, 2012
The effects of nociceptin peptide (N/OFQ)-receptor (NOP) system activation in the airwaysShailendra R Singh, Nikol Sullo, Bruno D'Agostino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoterAlison E John, Yong M Zhu, Christopher E Brightling, et al.
Chest|April 12, 2002
A comparison of the validity of different diagnostic tests in adults with asthmaCameron J Hunter, Christopher E Brightling, Gerrit Woltmann, et al.
American Journal of Respiratory Cell and Molecular Biology|December 10, 2014
Cigarette Smoke and the Induction of Urokinase Plasminogen Activator Receptor In Vivo: Selective Contribution of Isoforms to Bronchial Epithelial PhenotypeMichael A Portelli, Ceri E Stewart, Ian P Hall, et al.
Journal of Leukocyte Biology|January 28, 2005
Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migrationChristopher E Brightling, Davinder Kaur, Patrick Berger, et al.
Pageof 30